Stock Rich List
#13735 on the rich list of 14,644 insiders

Patrick D. Yeramian

Chief Medical Officer at Amylyx Pharmaceuticals. Based in Cambridge, Massachusetts.

$5.4M
in disclosed stock, −$86K (−1.58%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
13735th of 14,644
Companies held
1
Largest holding
AMLX, 100.0% of total
Latest SEC filing
Jan 9, 2024

What the $5.4M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Amylyx Pharmaceuticals AMLX
Common Stock
Directly205,605$26.20$5.4M100.0%Form 4, Jan 9, 2024

Share counts are the amounts Patrick D. Yeramian reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
13732Stewart Ellis
Director, Hippo Holdings. San Jose, CA
$5.4M−$40K (−0.73%)
13733Anastasis Nikolaou
10% owner, Acrivon Therapeutics
$5.4M−$616K (−10.26%)
13734Wiaczeslaw Smolokowski
10% owner, Acrivon Therapeutics
$5.4M−$616K (−10.26%)
13735Patrick D. Yeramian
Chief Medical Officer, Amylyx Pharmaceuticals. Cambridge, MA
$5.4M−$86K (−1.58%)
13736Seth Gersch
Director, Global Indemnity Group, LLC. Wilmington, DE
$5.4M−$231K (−4.11%)
13737David Lawrence Churchill
CHIEF TECHNOLOGY OFFICER, BETA Technologies. South Burlington, VT
$5.4M−$349K (−6.08%)
13738Jimmy R. Scripps
10% owner, The E.W. Scripps. Ft. Mitchell, KY
$5.4M−$412K (−7.10%)

Other Amylyx Pharmaceuticals insiders

All AMLX insiders

Questions

How much stock does Patrick D. Yeramian own?

Patrick D. Yeramian holds $5,386,851 in listed stock based on SEC filings and current prices, mostly Amylyx Pharmaceuticals (AMLX). That ranks 13735th on the Stock Rich List.

Is this Patrick D. Yeramian's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.